Sabrina Johnson | executive |
MarDee Haring-Layton | executive |
Douglas Tsao | analyst |
Brian Kemp Dolliver | analyst |
Catherine Novack | analyst |
Welcome to the conference call hosted by Daré Bioscience to review the company's first quarter financial results and to provide the general business update. This call is being recorded. My name is Alex, and I will be your operator for today.
With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer. Ms.